Hamid Emamekhoo

1. LOŽAR, Taja, BRUNNER, Matthew J., SHAH, Sujal I., KYRIAKOPOULOS, Christos E., EMAMEKHOO, Hamid (author, corresponding author). A case of metastatic renal cell carcinoma with concomitant Castleman’s disease treated with immunotherapy. Urology case reports. 2021, vol. 38, [article no.] 101720, str. 1-4, ilustr. ISSN 2214-4420. https://www.sciencedirect.com/science/article/pii/S2214442021001601?via%3Dihub, DOI: 10.1016/j.eucr.2021.101720. [COBISS.SI-ID 144700931]

2. HRIBERNIK, Nežka, HUFF, Daniel T., STUDEN, Andrej, ZEVNIK, Katarina, KLANEČEK, Žan, EMAMEKHOO, Hamid, ŠKALIČ, Katja, JERAJ, Robert, REBERŠEK, Martina (author, corresponding author). Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients : a pilot study. European journal of nuclear medicine and molecular imaging. [Print ed.]. 2022, vol. 49, iss. 6, str. 1857-1869, ilustr. ISSN 1619-7070. https://link.springer.com/article/10.1007/s00259-021-05650-3, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1007/s00259-021-05650-3. [COBISS.SI-ID 91868163]
project: P30 CA014520; funder: UWCCC
project: T32 CA009206; funder: National Cancer Institute of the National Institutes of Health
project: P3-0321; funder: The Slovenian Research Agency

3. SHAPIRO, Daniel D. (author, corresponding author), DOLAN, Brendan, LAKLOUK, Israa A., RASSI, Sahar, LOŽAR, Taja, EMAMEKHOO, Hamid, WENTLAND, Andrew L., LUBNER, Meghan G., ABEL, Edwin Jason. Understanding the tumor immune microenvironment in renal cell carcinoma. Cancers. 2023, vol. 15, no. 9, [article no.] 2500, str. 1-20, ilustr. ISSN 2072-6694. https://www.mdpi.com/2072-6694/15/9/2500, DOI: 10.3390/cancers15092500. [COBISS.SI-ID 152122883]